Conclusiones: Caso Estudio de las Heparinas
“Low-molecular-weight heparins are highly cost-effective for inpatient management of venous thrombosis”
“This treatment reduces costs when small numbers of patients are eligible for outpatient management”
Notes:
Las conclusiones del estudio de las heparinas son las siguientes:
1) low-molecular-weight heparins are highly cost-effective for inpatient management of venous thrombosis, and
2) low-molecular-weight heparins treatment reduces costs when small numbers of patients are eligible for outpatient management
Estas conclusiones son justificables, generalizables y aplicables en la práctica.